CARLSBAD, Calif., Feb. 28,
2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc.
(Nasdaq: IONS) today announced that management will participate in
fireside chats at the following investor conferences:
- TD Cowen 44th Annual Health Care Conference on
Tuesday, March 5, 2024
- Stifel 2024 Virtual CNS Days on Wednesday, March 20, 2024
A live webcast of these presentations can be accessed on the
Investors & Media section of the Ionis website at
https://ir.ionispharma.com/events-and-presentations/upcoming-events.
Replays will be available on the Ionis website within 48 hours and
will be archived for a limited time.
About Ionis Pharmaceuticals
For three decades, Ionis has invented medicines that bring better
futures to people with serious diseases. Ionis currently has five
marketed medicines and a leading pipeline in neurology, cardiology,
and other areas of high patient need. As the pioneer in
RNA-targeted medicines, Ionis continues to drive innovation in RNA
therapies in addition to advancing new approaches in gene editing.
A deep understanding of disease biology and industry-leading
technology propels our work, coupled with a passion and urgency to
deliver life-changing advances for patients. To learn more about
Ionis, visit Ionispharma.com and follow us on X (Twitter) and
LinkedIn.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-302072954.html
SOURCE Ionis Pharmaceuticals, Inc.